AferBio contém nutrientes que exercem efeitos positivos no sistema imune e digestório
Millions invested in P&D
Register on ANVISA
Clinical Nutrition Market
AferBio contains nutrients that exert
positive in the immune and digestive system
Objectives: to develop the commercial area and be a reference in oncological nutrition.
15 years in the market
THE AFERBIO COMPANY
This page was translated by Google Translator
For information, please contact us by e-mail: firstname.lastname@example.org or by telephone 55 + 19. 9.9779.6725
This information is educational and does not take the place of your trusted physician or nutritionist.
The Ministry of Health warns: "There is no proven scientific evidence that this food prevents, treats or cures diseases."
Research: in vitro, in vivo and clinical
Dear investor or entrepreneur, Aferbio Bioalimentos Ltda, founded in 2002, invites you to be part of this important project that aims at improving the quality of life and possibility of increased survival in people with cancer. The plan of action for the implementation of this project, already underway, involves the dissemination of AferBio to oncologists, nutrologists, hematologists and nutritionists. Participation in medical congresses and conducting further clinical research are also essential to the success of the project.
Product ready, with medical